Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the ...

Veiseh et al. synthesized a bioconjugate of chlorotoxin and the NIRF dye Cy5.5 that preferentially binds to glioma cells in a process dependent on matrix metalloproteinase-2 (32). When injected ...